FGFR2 gene amplification and clinicopathological features in gastric cancer

BACKGROUND: Frequency of FGFR2 amplification, its clinicopathological features, and the results of high-throughput screening assays in a large cohort of gastric clinical samples remain largely unclear. METHODS: Drug sensitivity to a fibroblast growth factor receptor (FGFR) inhibitor was evaluated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, K, Arao, T, Hamaguchi, T, Shimada, Y, Kato, K, Oda, I, Taniguchi, H, Koizumi, F, Yanagihara, K, Sasaki, H, Nishio, K, Yamada, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322955/
https://www.ncbi.nlm.nih.gov/pubmed/22240789
http://dx.doi.org/10.1038/bjc.2011.603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322955/
https://www.ncbi.nlm.nih.gov/pubmed/22240789
http://dx.doi.org/10.1038/bjc.2011.603

Ejemplares similares